ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
USP30-Mediated Deubiquitination of PEX5 Suppresses Pexophagy to Drive Tubular Injury in Diabetic Kidney Disease.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Diabetic kidney disease (DKD) is characterized by progressive tubular injury, yet the mechanisms linking metabolic stress to organelle dysfunction remain unclear. Here, utilizing human renal biopsies, db/db and high-fat diet with streptozotocin-induced diabetic mouse models, and cultured renal tubular epithelial cells (RTECs) exposed to 30 mM glucose, we demonstrate that impaired pexophagy drives peroxisomal dysfunction and tubular damage in DKD. Diabetic conditions induced marked accumulation of the peroxisomal membrane protein PMP70 (encoded by ABCD3/Abcd3) in RTECs, reflecting impaired peroxisomal turnover. We identified ubiquitin-specific peptidase 30 (USP30) as a contributor of this process. Expression profiling and localization analyses revealed that USP30 expression was significantly elevated in vivo and in vitro under high-glucose conditions and predominantly localized to RTECs. Global genetic depletion of USP30 restored peroxisomal function and metabolic homeostasis, enhanced pexophagy, and attenuated tubular injury. Mechanistically, USP30 antagonized the ubiquitination of the peroxisomal import receptor PEX5, thereby suppressing pexophagy. Furthermore, deletion of the essential autophagy factor ATG5 abolished the protective effects of USP30 deficiency. These findings reveal a critical role of USP30 mediated regulation of pexophagy in DKD and suggest that USP30 may serve as an experimental intervention target to alleviate tubular injury in DKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.